Gentofte Hospital is located in Gentofte within Copenhagen in Denmark. Administratively, it is part of the hospital service of Region Hovedstaden. The hospital primarily serves the municipalities of Gentofte, Lyngby-Taarbæk, and Rudersdal, with a population of about 175,000.

During the past decade, Center for Diabetes Research, Gentofte Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Diabetes Research, Gentofte Hospital" #1 collaborator was "University of Copenhagen" with 4 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Metropolitan University College" with 1 trials as a collaborator, "Research Unit for General Practice, Aarhus University" with 1 trials as a collaborator and "University Hospital, Gentofte, Copenhagen" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Center for Diabetes Research, Gentofte Hospital" are "Type 2 Diabetes" (4 trials), "Diabetes Mellitus, Type 2" (2 trials), "Glucose Metabolism Disorders" (2 trials), "Type2 Diabetes" (2 trials) and "Atopic Dermatitis/Eczema" (1 trials). Many other conditions were trialed in "Center for Diabetes Research, Gentofte Hospital" in a lesser frequency.

Most popular intervention types in "Center for Diabetes Research, Gentofte Hospital" are "Drug" (6 trials), "Other" (3 trials), "Behavioral" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Placebo Oral Tablet" (2 trials), "Standardised liquid meal" (2 trials) and ""cholestagel®" (Colesevelam)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Center for Diabetes Research, Gentofte Hospital" are 10 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Diabetes Research, Gentofte Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Center for Diabetes Research, Gentofte Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Diabetes Research, Gentofte Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".